Your institution may have access to this item. Find your institution then sign in to continue.
Title
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
Authors
Kandiel, A; Fraser, A G; Korelitz, B I; Brensinger, C; Lewis, J D
Abstract
Inflammatory bowel disease (IBD) is commonly treated with immunomodulators such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in IBD patients treated with these medications have been underpowered and have yielded conflicting conclusions.